Taylor H. Schreiber
Co-Founder, CEO & DirectorDr. Taylor H. Schreiber, M.D., Ph.D., is a Co-Founder of Shattuck Labs, Inc. since 2016 and also has been its Chief Executive Officer and Director since January 29, 2020 and 2017 respectively. Dr. Schreiber served as Chief Scientific Officer of Shattuck Labs, Inc. from January 2017 until January 29, 2020. From January 2011 to March 2017, he served as the Chairman of Scientific Advisors at Pelican Therapeutics, Inc. and also served as its Director. He served as Chief Scientific Officer of Heat Biologics, Inc. from July 23, 2015 to December 2016. Dr. Schreiber served as Vice President of Research and Development at Heat Biologics, Inc. from March 3, 2014 to July 23, 2015. Dr. Schreiber is a co-inventor of significant elements of Heat's ImPACT technology platform. He is the Founder and co-inventor of TNFRSF25 agonist technology. He served as Chairman of Scientific Advisory Board at Heat Biologics, Inc. January 1, 2017 until October 2017. He completed his post-doctoral fellowship and was nominated as a Future Leader in Cancer Research by the American Association for Cancer Research in 2011. He received his M.D. and Ph.D. degree from the Sheila and David Fuente Program in Cancer Biology at the University of Miami Miller School of Medicine. Dr. Schreiber received his B.A. in Biology from Bucknell University.
Positions
- Company NameShattuck Labs, Inc.Stock CodeSTTKPositionCo-Founder, CEO & DirectorColleagues
- GSGeorge S. GolumbeskiIndependent Chairman of the Board
- ARAndrew R. NeillChief Financial Officer
- ANArunthathy Nirmalini PanditeChief Medical Officer
- BHBrad HuckabeeVice President of Accounting & SEC reporting
- AAAbhinav A. ShuklaChief Technical Officer
- NWNeil W. GibsonIndependent Director
- HMHelen Marie BoudreauIndependent Director
- CBClay B. SiegallIndependent Director
